Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17810189 | 0.86 | PDE4A (0.50) | PDE4ACYP1A2CYP2C9CYP2C19GABRA2 | |
| SCHEMBL22519155 | 0.86 | CYP1A2 (0.59) | CYP1A2CYP2C9CYP2C19GABRA2GABRB2 | |
| SCHEMBL9923912 | 0.86 | RAB9A (0.55) | PDE4ACYP1A2CYP2C9CYP2C19GABRA2 | |
| SCHEMBL3499390 | 0.82 | SLC2A2 (0.58) | CYP1A2CYP2C9CYP2C19GABRA2GABRB2 | |
| SCHEMBL9925354 | 0.81 | MAPT (0.45) | PDE4ACYP1A2CYP2C9CYP2C19GABRA2 | |
| SCHEMBL24616739 | 0.81 | PDE4A (0.47) | PDE4AGABRA2GABRB2PTGS1PTGS2 | |
| SCHEMBL23387882 | 0.78 | PTGS1 (0.65) | PDE4ACYP1A2CYP2C9CYP2C19PTGS1 | |
| SCHEMBL29937800 | 0.77 | PTGS1 (0.42) | PDE4ACYP1A2CYP2C9CYP2C19GABRA2 | |
| SCHEMBL25296836 | 0.76 | CYP1A2 (0.39) | PDE4ACYP1A2CYP2C9CYP2C19GABRA2 | |
| SCHEMBL22519135 | 0.75 | NPC1 (0.56) | PDE4APTGS1PTGS2GAANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220217979-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220217979-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | C5, COX6C, C1S | PDE4A 1266/4885CYP1A2 57/4885CYP2C9 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.